IVIG, also known as intravenous immunoglobulin therapy, is the parenteral administration of healthy antibodies obtained from donors. It is given to manage various immune system disorders, including autoimmune diseases, inflammatory immune disorders, or other immunodeficiencies. However, similar to any other medical
Tecentriq (atezolizumab) is a type of immunotherapy used to treat certain types of cancers. It works by boosting the immune system, which then attacks cancer cells. Tecentriq has shown remarkable clinical trial results and is being praised as a potential
Miller Fisher syndrome (MFS) is a rare autoimmune nerve disorder that typically results in disruptions to coordination, balance, and functions of the upper body, including eye and facial movement. It has an estimated prevalence of approximately 1 in 100,000 individuals.
Colorectal cancer is a life-threatening disease that affects millions of people around the world. It is the third most diagnosed cancer. Fortunately, advances in medical science have led to the development of new treatments that can fight this deadly disease. One
Intravenous immunoglobulin (IVIG) premedication is one of the ways to minimize infusion-related side effects. Though intravenous immunoglobulin (IVIG) is well tolerated, some users may experience side effects such as flushing, headache, malaise, fever, chills, and fatigue. Rare and serious side effects
Myasthenia gravis (MG) is twice as common in women than in men, and early-onset myasthenia gravis is shown to affect women of childbearing age. How the disease progresses in pregnancy is unpredictable. Estimates suggest that 1 in 20,000 pregnant women
Intravenous Immunoglobulin (IVIG) is a medical treatment used to boost the immune system in people with certain autoimmune and immunodeficiency disorders. Patients undergoing IVIG treatment often ask the question: How will I know if IVIG is working effectively for me?
Metastatic pancreatic cancer is a devastating disease with a low survival rate. However, there's a promising chemotherapy drug for this condition — Onivyde (irinotecan liposome injection). It is used in combination with other chemotherapy medications to manage the targeted cancer.
Total parenteral nutrition (TPN), while often regarded as a lifeline for many patients, is not universally suitable. This life-saving technique has several contraindications. The term "contraindication" refers to a situation or state in which a specific treatment or intervention should
Intravenous immunoglobulin (IVIG) therapy has brought about significant improvements in the lives of numerous individuals dealing with autoimmune and immunodeficiency conditions. However, this treatment can be relatively expensive. For instance, a single IVIG infusion can cost anywhere from $100 to